RxDoctor Payments DataLook up a doctor →

Ashish Kabir, MD

Clinical Neurophysiology · Dalton, GANPI 1053727396

Payments from drug & device makers

$83,089in general payments, 2019–2025

Across 1,052 payments — averaging $78.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$24K
  • UCB, Inc.$23K
  • Argenx US, Inc.$10K
  • Catalyst Pharmaceuticals, Inc.$6K
  • Medtronic$3K
  • Livanova USA, Inc.$2K
  • plus $15K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Jazz Pharmaceuticals Inc.71$23,612
UCB, Inc.135$23,225
Argenx US, Inc.33$10,288
Catalyst Pharmaceuticals, Inc.18$5,768
Medtronic(2 entities)21$2,529
Livanova USA, Inc.18$2,412
AbbVie(2 entities)87$1,206
Boston Scientific4$1,143
Amneal Pharmaceuticals LLC51$825
Acadia Pharmaceuticals Inc53$745
Biogen31$739
SK Life Science, Inc.19$735
Eisai Inc.29$613
Amgen(2 entities)24$589
MDD US Operations, LLC16$576
Greenwich Biosciences, Inc.20$557
EMD Serono, Inc.24$534
Bristol Myers Squibb23$519
Kyowa Kirin, Inc.29$473
Neurocrine Biosciences, Inc.32$468
Teva Pharmaceuticals USA, Inc.29$440
Novartis27$402
Lilly USA, LLC16$394
Neurelis, Inc.15$360
Upsher-smith Laboratories LLC22$347
AstraZeneca(2 entities)17$342
Johnson & Johnson(2 entities)15$241
Biohaven Pharmaceutical Holding Company Ltd.18$193
Lundbeck LLC9$165
Sanofi7$163
Pfizer9$156
Mallinckrodt Hospital Products Inc.6$145
Otsuka America Pharmaceutical, Inc.7$136
CSL Behring6$134
GE HealthCare8$127
Portola Pharmaceuticals, LLC1$125
Vanda Pharmaceuticals Inc.6$124
Supernus Pharmaceuticals, Inc.15$121
Avanir Pharmaceuticals, Inc.8$119
E.r. Squibb & Sons, L.L.C.5$114
Axsome Therapeutics, Inc.5$107
Genentech USA, Inc.5$99
Acorda Therapeutics, Inc5$96
Impel Pharmaceuticals Inc.5$90
Adamas Pharmaceuticals, Inc.5$80
Arbor Pharmaceuticals, Inc.5$69
Cycle Pharmaceuticals Inc3$68
Biohaven Pharmaceuticals, Inc.5$64
Grifols USA, LLC2$43
Avion Pharmaceuticals3$42
Impel Pharmaceuticals LLC2$40
Aucta Pharmaceuticals, Inc.2$38
Azurity Pharmaceuticals, Inc.2$36
ANI Pharmaceuticals, Inc.2$34
TG Therapeutics, Inc.1$32
Sanofi-aventis U.S. LLC2$30
Zyla Life Sciences, Inc.2$29
Vertical Pharmaceuticals, LLC2$29
Merz Pharmaceuticals, LLC1$21
Springworks Therapeutics, Inc.1$19

How this compares

Too few clinical neurophysiology providers in Georgiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$185,382
Medicare patients
618
Services billed
2,360

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other clinical neurophysiology in Dalton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →